Rating History for Intellia Therapeutics (NTLA) by Wolfe Research
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/16/2026 | Andy Chen | Downgrade | Underperform (Peerperform) |
9.00 (N/A) |
13.30 (12.69) |
-4.59% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
